A detailed history of Geode Capital Management, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 636,082 shares of BHC stock, worth $5.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
636,082
Previous 527,813 20.51%
Holding current value
$5.39 Million
Previous $3.68 Million 40.95%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.22 - $8.26 $565,164 - $894,301
108,269 Added 20.51%
636,082 $5.18 Million
Q2 2024

Aug 09, 2024

BUY
$6.1 - $10.41 $606,437 - $1.03 Million
99,416 Added 23.21%
527,813 $3.68 Million
Q1 2024

May 13, 2024

SELL
$7.77 - $10.61 $6,449 - $8,806
-830 Reduced 0.19%
428,397 $4.55 Million
Q4 2023

Feb 13, 2024

BUY
$6.53 - $8.23 $811,966 - $1.02 Million
124,344 Added 40.78%
429,227 $3.44 Million
Q3 2023

Nov 13, 2023

SELL
$7.69 - $9.71 $85,135 - $107,499
-11,071 Reduced 3.5%
304,883 $2.51 Million
Q2 2023

Aug 11, 2023

BUY
$5.72 - $8.8 $38,266 - $58,872
6,690 Added 2.16%
315,954 $2.53 Million
Q1 2023

May 15, 2023

SELL
$6.28 - $9.85 $596,185 - $935,099
-94,934 Reduced 23.49%
309,264 $2.51 Million
Q4 2022

Feb 13, 2023

SELL
$6.09 - $7.93 $4.21 Million - $5.49 Million
-692,077 Reduced 63.13%
404,198 $3.12 Million
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $1.18 Million - $2.37 Million
257,627 Added 30.72%
1,096,275 $8.26 Million
Q2 2022

Aug 12, 2022

SELL
$7.06 - $23.63 $412,339 - $1.38 Million
-58,405 Reduced 6.51%
838,648 $7.12 Million
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $1.69 Million - $2.18 Million
78,279 Added 9.56%
897,053 $20.7 Million
Q4 2021

Feb 11, 2022

BUY
$23.0 - $29.01 $1.09 Million - $1.38 Million
47,480 Added 6.16%
818,774 $22.6 Million
Q3 2021

Nov 12, 2021

BUY
$25.04 - $30.06 $3.14 Million - $3.77 Million
125,512 Added 19.44%
771,294 $21.5 Million
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $562,013 - $669,990
20,489 Added 3.28%
645,782 $18.8 Million
Q1 2021

May 12, 2021

BUY
$21.37 - $34.38 $723,609 - $1.16 Million
33,861 Added 5.73%
625,293 $19.7 Million
Q4 2020

Feb 12, 2021

BUY
$15.31 - $21.12 $422,908 - $583,397
27,623 Added 4.9%
591,432 $12.2 Million
Q3 2020

Nov 13, 2020

BUY
$14.88 - $20.13 $497,988 - $673,690
33,467 Added 6.31%
563,809 $8.72 Million
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $433,400 - $667,846
32,562 Added 6.54%
530,342 $9.65 Million
Q1 2020

May 14, 2020

BUY
$12.98 - $30.25 $729,527 - $1.7 Million
56,204 Added 12.73%
497,780 $7.67 Million
Q4 2019

Feb 13, 2020

BUY
$18.89 - $31.89 $996,069 - $1.68 Million
52,730 Added 13.56%
441,576 $13.1 Million
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $1.46 Million - $1.79 Million
69,722 Added 21.85%
388,846 $8.43 Million
Q2 2019

Aug 14, 2019

BUY
$20.52 - $26.45 $242,279 - $312,295
11,807 Added 3.84%
319,124 $7.99 Million
Q1 2019

May 14, 2019

BUY
$20.23 - $26.29 $993,920 - $1.29 Million
49,131 Added 19.03%
307,317 $7.52 Million
Q4 2018

Feb 13, 2019

BUY
$17.64 - $28.32 $371,745 - $596,815
21,074 Added 8.89%
258,186 $4.74 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $4.89 Million - $6.09 Million
237,112 New
237,112 $6.04 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.